U of North Carolina School of Medicine awarded $3M to lead PTSD study

The U.S. Defense Department awarded $3 million to the University of North Carolina at Chapel Hill School of Medicine’s Institute for Trauma Recovery.

Advertisement

Researchers will evaluate the potential of a therapeutic agent to reduce the frequency and severity of acute stress disorder and post-traumatic stress disorder, according to an Oct. 6 news release.

The proposed trial will examine the safety and efficacy of ACER-801, or osanetant, in reducing acute stress response symptoms, posttraumatic stress disorder symptoms, and behavioral changes among patients after a motor vehicle collision.

“Historically, we have been able to provide emergency care to address immediate and long-term problems after visible wounds using tools such as sutures and antibiotics. However, we still have nothing to offer trauma survivors, whether in the emergency department or on the battlefield immediately after trauma, to prevent the development of ‘invisible wounds,'” said Samuel McLean, MD, MPH, professor of psychiatry and emergency medicine and director of the Institute for Trauma Recovery at the UNC School of Medicine.

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.